Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

ÅBYHØJ DYREKLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   1.6% 1.5% 1.5% 1.9% 1.8% 1.6% 18.4% 18.4%   Credit score (0-100)   76 78 76 68 71 73 8 8   Credit rating   A A A A A A B B   Credit limit (kDKK)   4.8 11.9 13.0 0.3 2.1 6.8 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   4,112 3,864 4,227 3,836 5,720 6,388 0.0 0.0   EBITDA   1,374 1,182 1,472 595 1,227 1,163 0.0 0.0   EBIT   871 689 965 414 1,032 1,001 0.0 0.0   Pre-tax profit (PTP)   777.7 588.6 878.3 321.6 1,001.8 1,452.4 0.0 0.0   Net earnings   617.6 459.1 682.3 247.3 775.5 1,127.3 0.0 0.0   Pre-tax profit without non-rec. items   778 589 878 322 1,002 1,452 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   2,901 3,017 2,931 3,560 3,773 3,642 0.0 0.0   Shareholders equity total   778 1,237 842 407 936 1,287 0.0 0.0   Interest-bearing liabilities   2,519 2,427 2,273 2,470 3,173 2,049 0.0 0.0   Balance sheet total (assets)   4,632 4,926 5,202 4,051 5,211 4,787 0.0 0.0   Net Debt   1,973 1,331 399 2,395 2,228 1,389 0.0 0.0     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   4,112 3,864 4,227 3,836 5,720 6,388 0.0 0.0   Gross profit growth   27.1% -6.0% 9.4% -9.2% 49.1% 11.7% -100.0% 0.0%   Employees   0 9 9 9 11 11 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 22.2% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,632 4,926 5,202 4,051 5,211 4,787 0 0   Balance sheet change%   -10.4% 6.3% 5.6% -22.1% 28.6% -8.1% -100.0% 0.0%   Added value   1,373.5 1,181.8 1,472.1 594.9 1,213.2 1,163.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -989 -784 -1,001 448 19 -293 -3,642 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   21.2% 17.8% 22.8% 10.8% 18.0% 15.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   17.8% 14.4% 19.1% 8.9% 25.9% 33.1% 0.0% 0.0%   ROI %   21.9% 18.0% 26.5% 13.2% 33.0% 42.8% 0.0% 0.0%   ROE %   60.6% 45.6% 65.6% 39.6% 115.5% 101.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   16.8% 25.1% 16.2% 10.1% 18.0% 26.9% 0.0% 0.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   143.6% 112.6% 27.1% 402.5% 181.6% 119.4% 0.0% 0.0%   Gearing %   323.9% 196.3% 269.9% 606.4% 339.2% 159.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.7% 4.1% 3.7% 3.9% 7.0% 7.8% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.6 1.2 1.0 0.1 1.0 0.6 0.0 0.0   Current Ratio   0.8 1.5 1.1 0.3 1.4 0.8 0.0 0.0   Cash and cash equivalent   545.7 1,096.4 1,874.0 75.0 945.0 660.5 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -203.4 466.2 174.8 -1,046.3 388.9 -266.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 131 164 66 110 106 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 131 164 66 112 106 0 0   EBIT / employee   0 77 107 46 94 91 0 0   Net earnings / employee   0 51 76 27 71 102 0 0